Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 24;13(6):1237.
doi: 10.3390/life13061237.

Effects of Dehydroepiandrosterone (DHEA) Supplementation on Ovarian Cumulus Cells following In Vitro Fertilization (IVF)/Intra-Cytoplasmic Sperm Injection (ICSI) Treatment-A Systematic Review

Woon Shu Yuan  1 , Muhammad Azrai Abu  1 , Mohd Faizal Ahmad  1 , Marjanu Hikmah Elias  2 , Abdul Kadir Abdul Karim  1
Affiliations
Review

Effects of Dehydroepiandrosterone (DHEA) Supplementation on Ovarian Cumulus Cells following In Vitro Fertilization (IVF)/Intra-Cytoplasmic Sperm Injection (ICSI) Treatment-A Systematic Review

Woon Shu Yuan et al. Life (Basel). .

Abstract

Despite many studies exploring the effects of DHEA supplementation, its application in IVF procedure continues to be a subject of debate owing to the inconsistent findings and the lack of rigorously designed, large-scale, randomized trials. Our review aims to explore the effectiveness of DHEA supplementation in ovarian cumulus cells following IVF/ICSI treatment. We conducted a literature search of Pub-Med, Ovid MEDLINE, and SCOPUS (inception to June 2022) for all relevant articles, including the keywords of "dehydroepiandrosterone/DHEA", "oocyte", and "cumulus cells". From the preliminary search, 69 publications were identified, and following a thorough screening process, seven studies were ultimately incorporated into the final review. Four hundred twenty-four women were enrolled in these studies, with DHEA supplementation being administered exclusively to women exhibiting poor ovarian response/diminished ovarian reserve or belonging to an older age demographic. The intervention in the studies was DHEA 75-90 mg daily for at least 8-12 weeks. The only randomized controlled trial showed no difference in clinical or cumulus cell-related outcomes between the control and treatment groups. However, the remaining six studies (two cohorts, four case-controls) showed significant beneficial effects of DHEA in cumulus cell-related outcomes compared to the group (older age or POR/DOR) without DHEA supplementation. All studies revealed no significant difference in stimulation and pregnancy outcomes. Our review concludes that DHEA supplementation did show beneficial effect on ovarian cumulus cells in improving oocyte quality for women of advanced age or with poor ovarian responders.

Keywords: Dehydroepiandrosterone (DHEA); cumulus cells; in vitro fertilization; oocyte quality; ovarian function.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Prisma flow chart of the searching strategy.
See this image and copyright information in PMC

References

    1. Gnoth C., Godehardt E., Frank-Herrmann P., Friol K., Tigges J., Freundl G. Definition and prevalence of subfertility and infertility. Hum. Reprod. 2005;20:1144–1147. doi: 10.1093/humrep/deh870. - DOI - PubMed
    1. Weil S.J., Vendola K., Zhou J., Adesanya O.O., Wang J., Okafor J., Bondy C.A. Androgen receptor gene expression in the primate ovary: Cellular localization, regulation, and functional correlations. J. Clin. Endocrinol. Metab. 1998;83:2479–2485. doi: 10.1210/jcem.83.7.4917. - DOI - PubMed
    1. Bachmann G., Bancroft J., Braunstein G., Burger H., Davis S., Dennerstein L., Goldstein I., Guay A., Leiblum S., Lobo R., et al. Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil. Steril. 2002;77:660–665. doi: 10.1016/S0015-0282(02)02969-2. - DOI - PubMed
    1. Hartmann B.W., Kirchengast S., Albrecht A., Laml T., Soregi G., Huber J.C. Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecol. Obstet. Investig. 1997;44:127–131. doi: 10.1159/000291503. - DOI - PubMed
    1. Burger H.G. Androgen production in women. Fertil. Steril. 2002;77((Suppl. 4)):S3–S5. doi: 10.1016/S0015-0282(02)02985-0. - DOI - PubMed

LinkOut - more resources